Cryotherapy for Inflammation and Recovery: What the Evidence Shows
At a Glance
- Whole body cryotherapy (WBC) exposes the body to extreme cold (-110 to -160 degrees Celsius) for 2 to 4 minutes, triggering norepinephrine release, reduced inflammatory cytokines, and cold shock protein activation.
- The evidence for athletic recovery is the strongest, with several RCTs showing reduced muscle soreness and faster strength recovery compared to passive rest.
- For chronic pain and inflammatory conditions like fibromyalgia and rheumatoid arthritis, early trials are promising but the evidence is still limited and the effect sizes are modest.
- The FDA has not cleared whole body cryotherapy for any medical indication. Individual localized cryotherapy devices (cryo-cuffs, ice packs) have medical clearances but WBC chambers do not.
- Sessions typically run 2 to 4 minutes and cost $50 to $100 each. Most protocols recommend daily sessions for 2 to 4 weeks for therapeutic goals.
Cryotherapy has become a staple of athletic recovery and wellness culture, with whole body cryotherapy chambers appearing in professional sports facilities, spas, and dedicated recovery centers worldwide. The claims range from legitimate (reduced post-exercise soreness) to implausible (anti-aging, weight loss, cancer prevention). Sorting through these requires looking at the actual physiology and the clinical trial record, not athlete testimonials or wellness marketing.
The honest summary: cryotherapy has real physiological effects, the evidence for athletic recovery is reasonably good, the evidence for chronic pain and inflammation is encouraging but preliminary, and the wellness and anti-aging claims are largely unsupported. Here is the full picture.
The Physiology of Cold Exposure: What Happens in the Body
When the body is exposed to extreme cold, it responds through a coordinated set of physiological mechanisms. Understanding which of these are activated, and how strongly, requires distinguishing between localized cryotherapy (ice packs, cryo-cuffs, cold water immersion of a limb) and whole body cryotherapy (WBC), where the entire body except the head is exposed to cryogenic temperatures.
Norepinephrine Release
Cold exposure triggers a significant sympathetic nervous system response, including release of norepinephrine from nerve terminals and the adrenal medulla. A 1993 study by Leppaluoto et al. published in the Finnish journal Acta Physiologica Scandinavica (n=10) demonstrated that a single WBC session at -110 degrees Celsius produced a 2 to 3 fold increase in plasma norepinephrine, with levels returning to baseline within 30 to 60 minutes. Norepinephrine has anti-inflammatory properties and is also involved in mood regulation, which explains some of the reported psychological benefits of cold exposure.
Cold Shock Proteins and Cellular Adaptation
Cold shock proteins (CSPs) are a class of proteins upregulated in response to rapid temperature drops. The best-studied in humans is RNA-binding motif protein 3 (RBM3), which has been shown in animal studies to promote synaptic repair and protect against neurodegeneration. Cold shock protein activation in response to WBC in humans has been demonstrated in blood samples, but the clinical significance of this in healthy adults receiving brief cold exposure is not established. The CSP angle is often cited in anti-aging and neuroprotection marketing, but the evidence for meaningful clinical benefit in humans from short cold exposures is preliminary at best.
Cytokine and Inflammatory Marker Changes
Multiple studies have measured inflammatory markers before and after WBC sessions in both athletes and clinical populations. A 2010 study by Lubkowska et al. in the Journal of Thermal Biology (n=25) found that a 10-session WBC protocol produced significant reductions in IL-6 and TNF-alpha, along with increased IL-10 (an anti-inflammatory cytokine). A 2013 study by Banfi et al. in the British Journal of Sports Medicine (n=10 elite rugby players) found reduced CRP and IL-6 following a series of WBC sessions during a training block.
The cytokine changes are real but relatively modest in magnitude. They are comparable in direction (though not magnitude) to what is seen with exercise itself, which also reduces chronic inflammation through repeated acute inflammatory responses. Whether these changes translate to meaningful clinical outcomes depends heavily on the baseline inflammatory state of the individual.
Evidence for Athletic Recovery
Athletic recovery is where WBC has the most RCT evidence. The key question is whether WBC reduces delayed onset muscle soreness (DOMS) and accelerates functional recovery faster than passive rest or competing recovery modalities like contrast water therapy or cold water immersion (CWI).
A 2015 Cochrane review by Bleakley et al. analyzed 4 RCTs comparing WBC to passive recovery or control in athletes. The review found that WBC produced significantly less post-exercise muscle soreness than passive recovery, with effect sizes of 0.6 to 0.9. However, the reviewers noted that study quality was variable and sample sizes were small, limiting confidence in the estimates.
A 2017 RCT by Guilhem et al. in the International Journal of Sports Physiology and Performance (n=26 elite judo athletes) compared WBC to far-infrared therapy and passive recovery following an intense training block. WBC produced faster recovery of muscle torque and reduced perceived soreness at 24 and 48 hours compared to both control conditions. Evidence grade: Moderate for reducing DOMS and subjective recovery. Emerging for performance-related outcomes.
WBC vs. Cold Water Immersion
Cold water immersion (CWI), which involves sitting in an ice bath at roughly 10 to 15 degrees Celsius for 10 to 15 minutes, has a longer and more substantial evidence base than WBC. When directly compared, CWI and WBC produce broadly similar recovery outcomes, with some studies favoring CWI. Given that ice baths cost essentially nothing compared to a $50 to $100 WBC session, the practical question of whether WBC is worth the premium is legitimate. The answer likely depends on individual tolerance: many people find WBC easier to tolerate than full-body ice immersion, which may affect compliance with recovery protocols.
Evidence for Chronic Pain and Inflammatory Conditions
Fibromyalgia
Fibromyalgia is characterized by widespread musculoskeletal pain, fatigue, and sleep disturbance, with an underlying neurological hypersensitivity component. Several small studies have examined WBC for fibromyalgia with encouraging results. A 2017 study by Bettoni et al. in Clinical Rheumatology (n=30) found that 15 WBC sessions over 3 weeks reduced VAS pain scores by 30% and improved fatigue ratings significantly compared to a control group, with effects maintained at 3 months. Evidence grade: Preliminary for fibromyalgia, but the effect size is meaningful enough to warrant further investigation.
Rheumatoid Arthritis
WBC has been used in European rheumatology settings, particularly in Germany and Poland, as an adjunctive treatment for rheumatoid arthritis (RA) for several decades. A 2016 study by Szczepanska-Gieracha et al. in the European Journal of Physical and Rehabilitation Medicine (n=46 RA patients) found that WBC combined with kinesiotherapy produced greater improvements in pain and functional scores compared to kinesiotherapy alone. The anti-inflammatory cytokine effects of WBC may complement pharmacological management in RA, though no studies have examined whether WBC reduces the need for DMARDs or biologics. Evidence grade: Preliminary.
Ankylosing Spondylitis and Inflammatory Arthropathies
Several small studies from Eastern European rheumatology centers have examined WBC in ankylosing spondylitis and other inflammatory arthropathies, generally showing modest pain and stiffness improvements. The evidence is thinner and more methodologically limited than for fibromyalgia or RA. These conditions are better managed primarily through established pharmacological treatments, with WBC potentially serving as an adjunctive tool. Evidence grade: Preliminary.
Localized vs. Whole Body Cryotherapy
| Feature | Whole Body Cryotherapy (WBC) | Localized Cryotherapy | Cold Water Immersion |
|---|---|---|---|
| Temperature | -110 to -160 degrees Celsius (air) | Varies: -30 to -80 degrees Celsius (device-dependent) | 8 to 15 degrees Celsius (water) |
| Duration | 2 to 4 minutes | 5 to 10 minutes per site | 10 to 20 minutes |
| Systemic effects | Yes (norepinephrine, cytokines, CNS) | Minimal beyond treated area | Yes (strong sympathetic response) |
| Best evidence for | Athletic recovery, fibromyalgia, RA adjunct | Acute soft tissue injury, localized pain, tendinopathy | Athletic recovery (strongest evidence) |
| FDA status | Not cleared for any medical indication | Many devices FDA-cleared for specific uses | No device (technique) |
| Cost per session | $50 to $100 | $30 to $75 | Minimal (home ice bath) |
| Risks | Frostbite (if wet skin), breathing cold air, rare vasovagal response | Frostbite if excessive, nerve damage if too cold | Hypothermia if prolonged, cardiovascular stress |
Localized cryotherapy, including the application of ice packs, cryo-cuffs, and targeted cryo devices, has stronger evidence for acute injury management than WBC. The R.I.C.E. (rest, ice, compression, elevation) protocol for acute soft tissue injuries has been the standard for decades, though more recent guidelines have shifted toward recommending less aggressive icing to avoid blunting the acute inflammatory phase that is necessary for healing. For acute injuries, the current recommendation is gentle, brief cold application for pain relief rather than prolonged icing.
FDA Regulatory Status and Safety Concerns
The FDA has specifically stated that it has not approved or cleared whole body cryotherapy devices for any medical indication, and that cryotherapy chambers should not be marketed with medical claims. The agency sent warning letters to several WBC manufacturers in 2016 regarding unsupported medical claims. WBC facilities continue to operate as spa or wellness services rather than medical practices, which means they are not subject to the same oversight as medical devices or procedures.
Safety concerns with WBC are real but manageable with proper protocols. Frostbite is the most significant risk and occurs when the skin is wet or when protective gear (gloves, socks, ear protection) is inadequate. The exposure time is short enough that frostbite in properly protected individuals is rare. Deaths have been reported from WBC, including a 2015 case where a Nevada spa employee was found dead in a WBC chamber after apparently entering alone and outside operating hours. Proper protocols require attendant supervision throughout the session. People with cold urticaria, Raynaud’s phenomenon, cryoglobulinemia, cardiovascular disease, or severe hypertension should not use WBC without physician clearance.
Practical Session Protocols
For athletic recovery, most protocols involve WBC sessions within 1 to 2 hours post-exercise, 3 to 5 times per week during high training load periods. Single sessions are used acutely around intense competition or training blocks. For chronic pain applications, clinical studies have generally used 10 to 20 sessions over 2 to 4 weeks as an induction protocol, with maintenance sessions as needed based on response.
Before each session, the skin must be completely dry and all metal jewelry removed. Protective gloves, wool socks, and wooden clogs are standard. The head remains outside the chamber. Most providers check contraindications at each visit. Sessions typically last 2 to 4 minutes, with the first session kept shorter (1 to 2 minutes) to assess tolerance.
The Bottom Line
Whole body cryotherapy has real physiological effects including norepinephrine release, cytokine modulation, and cold shock protein activation. The evidence for reducing post-exercise muscle soreness and accelerating athletic recovery is reasonably strong, though cold water immersion may achieve similar results at much lower cost. For chronic pain conditions like fibromyalgia and rheumatoid arthritis, early evidence is promising but not yet sufficient to position WBC as a first-line or standard adjunct treatment.
The wellness claims, including anti-aging, weight loss, and general immune enhancement, are not supported by clinical trial evidence. If you are an athlete or someone managing chronic pain who wants to try cryotherapy, the risk profile is low when proper protocols are followed, and the athletic recovery benefits are real enough to justify the cost for many users. Go in knowing what the evidence actually supports, use it as part of a broader recovery or treatment strategy, and do not expect it to do things the clinical trials have not demonstrated it can do.
